PRESS RELEASE published on 08/04/2025 at 07:00, 1 year 2 months ago Inside Information / Other news releases Innate Pharma discloses total shares outstanding and voting rights as of August 1, 2025. The company is a global biotech developing immunotherapies for cancer patients Voting Rights Biotechnology Immunotherapy Innate Pharma Shares Outstanding
BRIEF published on 07/04/2025 at 07:05, 1 year 3 months ago Innate Pharma Announces Share and Voting Rights Update Voting Rights Shares Euronext Nasdaq Innate Pharma
PRESS RELEASE published on 07/04/2025 at 07:00, 1 year 3 months ago Inside Information / Other news releases Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable) Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 1 year 3 months ago Innate Pharma to Participate in Key Investor Conferences Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma
PRESS RELEASE published on 06/17/2025 at 07:00, 1 year 3 months ago Inside Information / Other news releases Innate Pharma to participate in H.C. Wainwright and Wolfe Research healthcare conferences showcasing their innovative immunotherapy approaches. Global biotech company expanding portfolio Biotechnology Immunotherapy Clinical-stage Innate Pharma Healthcare Conferences
BRIEF published on 06/13/2025 at 07:05, 1 year 3 months ago Innate Pharma's IPH6501 Shows Potential in Lymphoma Treatment Innate Pharma Preclinical Results IPH6501 Lymphoma R-CHOP
PRESS RELEASE published on 06/13/2025 at 07:00, 1 year 3 months ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
BRIEF published on 05/13/2025 at 07:05, 1 year 4 months ago Innate Pharma Reports First Quarter 2025 Results Financial Results Clinical Trials Innate Pharma Sanofi Investment Lacutamab FDA
PRESS RELEASE published on 05/13/2025 at 07:00, 1 year 4 months ago Inside Information / News release on accounts, results Innate Pharma reports Q1 2025 business update with €15 million investment by Sanofi, FDA Breakthrough Therapy Designation for lacutamab, and cash position of €72.5 million FDA Financial Results Sanofi Innate Pharma Q1 2025
BRIEF published on 05/02/2025 at 15:27, 1 year 5 months ago Sanofi increases its stake in Innate Pharma Capital Actions Crossing Thresholds Sanofi Innate Pharma
Published on 10/10/2026 at 04:45, 2 days 4 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 7 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 2 days 7 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 2 days 10 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 2 days 11 hours ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/12/2026 at 09:35, 8 minutes ago Bybit Supports Stocks Trading, Giving Eligible Global Users Access to 1,000+ U.S. Stocks and ETFs
Published on 10/12/2026 at 09:30, 14 minutes ago PFISTERER Holding SE – Conversion to Registered Shares Successfully Completed
Published on 10/12/2026 at 09:05, 38 minutes ago From Large Furniture Choices to Better Living Spaces: Over 1 Million UK Customers Choose Aosom
Published on 10/12/2026 at 09:05, 38 minutes ago Aurzen Brings Roku TV Projection to Germany with EAZZE E1R, a Netzwelt Innovation Award Winner at IFA 2026
Published on 10/12/2026 at 09:00, 43 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 10/09/2026 at 19:27, 2 days 14 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/08/2026 at 18:30, 3 days 15 hours ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 3 days 15 hours ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 3 days 15 hours ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
